Differences in the use of fluoroquinolones therapy did not reach statistical significance (24.3% in PRPA group (7 of 70 patients) vs. 13.1% in PSPA group (20 of 153 patients); P = 0.058).
← all excerpts
Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
1
0.0580
0.0580